Comments

View 3 Images

A new obesity drug has been revealed as scientists embark on human trials. Named RES-010, the new type of weight loss medication aims to address the underlying causes of obesity by reprograming how the body uses fat and the energy it gets from food. ‌

This could see people losing weight while eating the same amount of food. Around two-thirds of adults in Scotland are overweight or obese according to Obesity Action Scotland. ‌

Obesity is a global and complex public health concern. It can increase a person's risk for a range of chronic diseases and health issues like cardiovascular disease, type 2 diabetes, cancer, liver, and respiratory disease. It can also impact on mental health. ‌

View 3 Images

Other weight loss medications , like the GLP-1

See Full Page